SPONSOR

West China Hospital

Total Trials

Recruiting

Phases

Phase 1, Phase 4, Phase 1, Phase 2, Phase 2, Phase 3, Phase 2, Phase 3

Conditions studied: Malignant Tumor Metabolic Dysfunction-Associated Steatohepatitis Hepatic Steatosis Living Liver Donors Advanced Melanoma HPV-positive Oropharyngeal Squamous Cell Carcinoma Radiation-Induced Skin Fibrosis Head and Neck Squamous Cell Carcinoma Esophagus Cancer Colorectal Cancer

West China Hospital is a clinical research sponsor with 21 registered studies on ClinicalTrials.gov, of which 21 are actively recruiting participants. Research covers conditions including Malignant Tumor, Metabolic Dysfunction-Associated Steatohepatitis, Hepatic Steatosis, Living Liver Donors.

The trial portfolio spans Phase 1, Phase 4, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — West China Hospital

How many clinical trials has West China Hospital sponsored?

ClinicalMetric currently tracks 21 clinical trials sponsored by West China Hospital, of which 21 are actively recruiting participants. These trials cover conditions including Malignant Tumor, Metabolic Dysfunction-Associated Steatohepatitis, Hepatic Steatosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does West China Hospital research focus on?

West China Hospital clinical trials span Malignant Tumor, Metabolic Dysfunction-Associated Steatohepatitis, Hepatic Steatosis, Living Liver Donors, Advanced Melanoma, and additional conditions. The research pipeline includes Phase 1, Phase 4, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a West China Hospital clinical trial?

To participate in a West China Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all West China Hospital trials with current recruitment status updated daily.

West China Hospital

Frequently Asked Questions — West China Hospital

Clinical Trials by West China Hospital

Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy

Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC

Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis

A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma

YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment

Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors

A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma

Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors

Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid Cancer

A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 in Patients With Mucopolysaccharidosis Type I

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma

Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR)

Individualized ANH for Non-cardiac Surgery

A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCC

Physiological Studies in the Prone Position in Patients With ARDS

Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal Cancer Who Received the Zidovudine Combination Regimen in the Real World